The hottest Cardiovascular Health Substack posts right now

The expanding GLP-1 drug family shows potential for treating obesity with new triple agonist drugs.
Clinical trials with G-agonists reveal reductions in major cardiovascular events and heart failure symptoms.
GLP-1 drugs have shown promise in treating early type 1 diabetes, cognitive function, alcohol use disorder, and more.

The trial data for Semaglutide (Wegovy) for cardiovascular risk reduction was manipulative and lacking in transparency, raising concerns about conflicts of interest and data sharing.
The study demographics were concerning, with a lack of diversity and representation, particularly skewed towards white men, older participants, and those with existing heart disease.
The actual cardiovascular risk reduction with Semaglutide was much lower than claimed, highlighting issues with study design, data presentation, and potential overemphasis on specific demographics in the results.

Lower blood pressure targets are beneficial for heart health, brain health, and overall mortality.
More stringent blood pressure goals may require lifestyle changes or additional medications.
SPRINT findings showed benefits for all age groups, regardless of other health factors.

A recent study found no increase in cardiovascular risk with testosterone therapy for men with low T levels.
Make sure to confirm low T levels before starting testosterone therapy.
Weight loss and exercise can help alleviate symptoms related to low T without the use of testosterone therapy.

Menopause hormone therapy can be safe and beneficial when prescribed appropriately, considering individual risks and benefits.
Estrogen doesn't cause breast cancer for the majority of women; the benefits of hormone therapy often outweigh the risks.
Women going through menopause should have open conversations with healthcare providers to make informed decisions about hormone therapy.

Get a weekly roundup of the best Substack posts, by hacker news affinity:

ApoB is a crucial biomarker linked to cardiovascular health.
High levels of ApoB can lead to atherosclerosis, affecting brain function.
Managing ApoB levels involves dietary adjustments and understanding genetic factors.

First study to find micro/nano plastics in atheroma plaque with significant link to poorer health outcomes
Plastics are pervasive and harmful, found in various body tissues and linked to health issues like cancer and premature births
Urgent need to address plastic pollution - focus on reducing single-use plastics and transitioning away from fossil fuels

Blood levels of vitamin K mainly reflect recent intake rather than long-term nutritional status. Testing the carboxylation status of vitamin K-dependent proteins is a more accurate way to assess vitamin K status.
Clotting disorders are a significant concern, so tests for vitamin K-dependent clotting factors are well-established. These tests prioritize clotting function over other aspects of vitamin K's role.
The most common marker for vitamin K status in research studies is the carboxylation status of osteocalcin, reflecting vitamin K status in bone. A promising future marker is desphospho-uncarboxylated matrix Gla protein for assessing vascular health.